Now scientists are investigating their potential impact on the brain
In Ohio, a bipartisan bill introduced in July (HB 388) would allow state employees to receive reimbursement for GLP-1 drugs
18 Two landmark trials followed, establishing RAAS blockade as the standard of care for preventing DKD
An informed consent decision should be made and documented before starting any medications that could potentially blind the patient, and with GLP-1 agonists, I see different scenarios for informed consent
In contrast, derivatives of zidovudine (127, 128), glutathione conjugate of L-dopa (126), modified glutathione derivative of L-dopa (151), dopamine-gluconamine and gluconamide (140) as well as ketoprofen derivatives (113) demonstrated pharmacological activity and should be considered as analogues
Two months is a conservative recommendation that errs on the side of caution, she says